Why the study?
Does 32 x 0.5-MDCTA reliably exclude significant coronary stenoses in patients with complex and advanced CAD?
Population
Patients with complex and advanced atherosclerotic disease, including those with heart rhythm and frequency…
Design
Cross-sectional
Authors
Loading...
Supports MDCTA for stenosis exclusion in advanced CAD with MRI contraindications; leaves open prospective validation before practice change.
Does 32 x 0.5-MDCTA reliably exclude significant coronary stenoses in patients with complex and advanced CAD?
32 x 0.5-MDCTA reliably excludes significant coronary stenoses in patients with advanced CAD, offering an alternative imaging modality for those with MRI contraindications like pacemakers.
Sülhattin Arslan (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: